Potentially inappropriate medications for patients with heart failure: a nationwide retrospective study from 2012 to 2022
These results suggest that typical PIMs for hospitalised patients with HF have declined during the past decade. Medical providers should contribute to optimising medications that minimise PIM administration to patients with HF. In the future, PIMs for patients with HF may need to be monitored as a safety indicator.
Authors
- Shunichi Ishii (ORCID: https://orcid.org/0000-0001-5194-9169)
- Mio Ebato (ORCID: https://orcid.org/0000-0001-8594-1552)
- Yoshitaka Iso (ORCID: https://orcid.org/0000-0002-4687-0453)
- Shoko Nakamura (ORCID: https://orcid.org/0000-0002-9424-8773)
- Tomiko Sunaga (ORCID: https://orcid.org/0000-0002-1316-5192)
- Michiru Nagao
Institutions
- SHOWA Medical University (JP)
- Hoshi University (JP)
- SHOWA Medical University Northern Yokohama Hospital (JP)
- SHOWA Medical University Fujigaoka Hospital (JP)
- SHOWA Medical University Hospital (JP)
Publication Details
- Journal
- Journal of Pharmaceutical Policy and Practice
- Published
- 2025-12-08
- DOI
- https://doi.org/10.1080/20523211.2025.2594821
- Primary Topic
- Heart Failure Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00